Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of BYL719 and Nab-Paclitaxel in Subjects With Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

NCT02379247 is registered in ClinicalTrials.gov with Priyanka Sharma as lead sponsor.

NCT NCT02379247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of BYL719 and Nab-Paclitaxel in Subjects With Locally Recurrent or Metastatic HER-2 Negative Breast Cancer
Lead sponsor
Priyanka Sharma
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2015
Completion date
March 31, 2022
Enrollment
43 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer